Circulation Journal Official Journal of the Japanese Circulation Society http://www. j-circ.or.jp duction process by avoiding additional sewing and may also help to avoid leakage after implantation. 3 We previously reported excellent hydrodynamic performance of the SMV within the environment of a MV simulator capable of generating identical test conditions. 3 However, no reports have been presented about its in vivo use and the implantation technique in the mitral position remains to be established. Therefore, we evaluated hemodynamic performance and valve function immediately after replacement with this novel SMV in an animal model.
MethodsWe used 7 female pigs (Hiyoshi Farm Co Ltd, Kyoto, Japan) for a procedure utilizing the new SMV under standard cardioalve replacement is a well-established modality for treatment of mitral valve (MV) disease. 1 However, in young patients, including women of childbearing age, valve replacement still presents a problem because of the limited durability of bioprostheses, particularly when implanted in the mitral position and because of the difficulties associated with the long-term anticoagulation required for mechanical prostheses. 2 To improve the current situation, we need to find an optimal prosthesis resembling native MV anatomy and develop a new surgical treatment strategy for patients with indication. The stentless MV (SMV), newly designed by Hitoshi Kasegawa, embodies special characteristics in its design, as the large anterior leaflet has commissures formed without any suture line, and the folded structure of the 2 commissures streamlines the pro- Background: We conducted in vivo examinations of a newly designed stentless mitral valve (SMV), formed by suturing 2 leaflets with the "legs" serving as chorda tendinea, made from bovine pericardium, to a flexible ring.
V
Methods and Results:Seven pigs underwent implantation of the SMV constructed with a 23-mm (n=5) or 25-mm (n=2) Duran ring. Baseline echocardiography examinations were used to evaluate the annular anteroposterior diameter, and distance between the mitral annulus (MA) and papillary muscles (PMs) to determine SMV-leg length. After removing the native valve, the SMV-legs were fixed to the anterior and posterior PMs, followed by fixation of the ring to the native MA. Immediately after surgery, all animals presented none or trivial mitral regurgitation, with mean and peak trans-SMV pressure gradient values of 1.9±0.8 and 6.0±3.1 mmHg, respectively. The mean length of the SMV-leg was 19.4±3.9 mm, which correlated with the distance between anterior and posterior MA-PM (r=0.96 and 0.94, respectively, P<0.01 for both). The discrepancy between the anteroposterior diameter of the ring (outside diameter) and that of the native valve was 1.0±2.9 mm, which correlated with the trans-SMV pressure gradient (r=0.81, P=0.025).
Conclusions:In our preliminary study, the SMV demonstrated excellent diastolic inflow dynamics and closing function in vivo. Preoperative precise assessment of MV configuration may serve as a basis for sel...